18. Orchard Therapeutics $150M
Round: Series C
Description: London-based Orchard Therapeutics is a biotechnology company dedicated to transforming the lives of patients through innovative gene therapies.
Industry: Biotechnology, Genetics, Health Care, Health Diagnostics
Page 4 of 25
